Article

Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection

2021-03-08

Abstract excerpt

<h4>Background</h4> The SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus 2) has led to more than 114 million COVID-19 cases and >2.5 million deaths worldwide. Epidemiological analysis has revealed that the risk of developing severe COVID-19 increases with age. Despite a disproportionate number of older individuals and long-term care facilities being affected by SARS-CoV-2 and COVID-19, very little is unde...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 06a47701-c725-504d-82b7-2ad8e6760cd9
DOI: 10.1101/2021.03.05.21252707

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infectionDOI 10.1101/2021.03.05.21252707Read

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infectionSemantic proximity Read

Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and AgeSemantic proximity Read

Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalizationSemantic proximity Read

SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody DynamicsSemantic proximity Read

Early functional maturation of anti-Spike antibodies predicts SARS-CoV-2 RNA clearance in mild infectionSemantic proximity Read

Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan – Implications for the Longevity of Antibodies Against SARS-CoV-2Semantic proximity Read

Persistence of anti-SARS-CoV-2 antibodies in non-hospitalized COVID-19 convalescent health care workersSemantic proximity Read

Reduced Antibody and Cellular Immune Responses Following Dual COVID-19 Vaccination Within Infection-Naïve Residents of Long-Term Care FacilitiesSemantic proximity Read

The Dynamic Changes of Antibodies against SARS-CoV-2 during the Infection and Recovery of COVID-19Semantic proximity Read

SARS-CoV-2 spike-binding antibody longevity and protection from re-infection with antigenically similar SARS-CoV-2 variantsSemantic proximity Read

Longitudinal characterization of humoral and cellular immunity in hospitalized COVID-19 patients reveal immune persistence up to 9 months after infectionSemantic proximity Read

'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19Semantic proximity Read